|
|
Çѹ̾àÇ°, ±â´ë°¨ÀÌ Ä¿Áö´Â ±¸°£ |
¹Úº´¿ì ±âÀÚ |
2018-08-27 08:13 |
¿¡½ºÆ¼ÆÊ, ½ÇÀûºÎÁøº¸´Ù ½Å¾àAPIÀÇ ÀáÀç·ÂÀ» Æò°¡ÇÑ´Ù |
¹Úº´¿ì ±âÀÚ |
2018-08-25 08:07 |
¼¼¿î¸ÞµðÄ®,¼ºÀå Áغñ ¿Ï·á |
¹Úº´¿ì ±âÀÚ |
2018-08-24 08:31 |
ÇコÄɾî Daily(8/24)-½ÅÇѱÝÀ¶ÅõÀÚ |
¹Úº´¿ì ±âÀÚ |
2018-08-24 08:26 |
°£¼¼Æ÷¾Ï Ä¡·á Á¦ ³Ø»ç¹Ù¿¡ ´ëÇ×ÇÏ´Â ·»ºñ¸¶, FDAÇã°¡(±è¹ÌÇö AnalystÀÇ Bio insight) |
¹Úº´¿ì ±âÀÚ |
2018-08-23 08:21 |
¶óÀÎ |
ÇコÄɾî Daily(8/23)-½ÅÇѱÝÀ¶ÅõÀÚ |
¹Úº´¿ì ±âÀÚ |
2018-08-23 08:14 |
¾ÆÀ̼¾½º, Downside risk Á¦ÇÑÀû |
¹Úº´¿ì ±âÀÚ |
2018-08-23 08:12 |
Á¦¾à/¹ÙÀÌ¿À,¹Ì±¹ 7 ¿ù ¹ÙÀÌ¿À½Ã¹Ð·¯ ó¹æµ¥ÀÌÅÍ |
±è»ç¶û ±âÀÚ |
2018-08-22 09:47 |
Á¦¾à-SK Pharma Weekly(8/16~21) |
±è»ç¶û ±âÀÚ |
2018-08-22 09:10 |
ÇコÄɾî Daily(8/22-½ÅÇѱÝÀ¶ÅõÀÚÁõ±Ç) |
±è»ç¶û ±âÀÚ |
2018-08-22 09:04 |
¶óÀÎ |
ÈÞÁ©, ÇØ¿Ü NDR Èıâ |
¹Úº´¿ì ±âÀÚ |
2018-08-22 08:50 |
Á¦¾à/¹ÙÀÌ¿À,ÃÖ´ë ¾ÇÀç¿´´ø R&D ȸ°è À̽´, Å« °íºñ ³Ñ°å´Ù |
¹Úº´¿ì ±âÀÚ |
2018-08-21 08:28 |
ÇコÄɾî Daily(8/21)-½ÅÇѱÝÀ¶ÅõÀÚ |
¹Úº´¿ì ±âÀÚ |
2018-08-21 08:22 |
¸¶Å©·ÎÁ¨, ÁÖ°¡ ±Þµî°ü·Ã ÄÚ¸àÆ® |
±è»ç¶û ±âÀÚ |
2018-08-21 08:20 |
[Á¦¾à/¹ÙÀÌ¿À] ¾ÆÀÌ ¸Ó´Ï(Eye-Money) : µ·ÀÌ µÇ´Â ¾È°ú½ÃÀå |
¹Úº´¿ì ±âÀÚ |
2018-08-21 07:26 |
¶óÀÎ |
»ïõ´çÁ¦¾à, Àǽɿ¡¼ ¹ÏÀ½À¸·Î |
±è»ç¶û ±âÀÚ |
2018-08-21 06:56 |
¾ËÅ׿ÀÁ¨, ½ÃÀå¼±Åðú °øµ¿°³¹ß·Î ¼º°øÈ®·üÀ» ³ôÀδ٠|
¹Úº´¿ì ±âÀÚ |
2018-08-21 06:52 |
·çÆ®·Î´Ð, »õ·Î¿î ½ÃÀå¿¡ ´ëÇÑ Áغñ |
¹Úº´¿ì ±âÀÚ |
2018-08-21 06:47 |
¾ÆÀÌÁø, ºñÁõ½Ä¼º ´ç´¢¸Á¸·Áõ(NPDR) Ä¡·áÁ¦¿¡ ´Ù½Ã ÁÖ¸ñÇÒ ½ÃÁ¡ |
¹Úº´¿ì ±âÀÚ |
2018-08-21 06:42 |
¿¤¾ØÄÉÀ̹ÙÀÌ¿À, ½Å±Ô½ÃÀå ÁøÃâ·Î Áö¼Ó¼ºÀå |
¹Úº´¿ì ±âÀÚ |
2018-08-20 10:01 |
|